Building the next generation of cell-based medicines
Jing-Meng Stem Cell Technology Co., Ltd is a cell therapy company driven by rigorous scientific discovery and focused on the development of breakthrough treatments for various different types of disorders.
Read More
How Our Technology Improves Disease Diagnosis and Prognosis Prediction
Clinical Diagnostics Development: Turn-key services to support diagnostic programs from concept to commercialization
Read More
Tackling Cancer The New Way
Precision Medicines is dedicated to improving the lives of cancer patients through developing novel targeted medicines with companion biomarkers
Read MoreOur Commitment
Understanding Science, Implement Innovation, Mutual Cooperation, and win-to-win challenge, Creating Health for the Best Achievements of Life Science and Technology and beneficiary for mankind.
About Jing-Meng Stem Cells
The company is committed to the basic theoretical research of human cell therapy, the research and development and industrialization of application technology, the provision of professional cell technology services and related medical and health care biol
Scientific Team
Jing - Meng is founded by world-class researchers at the forefront of stem cell biology. We have built an outstanding team of scientists that work tirelessly to advance cell-based medicines to the clinic & diagnosis. Our workstation owned by the Chinese A
Board of Directors
Regenerative medicine has the potential to transform healthcare, enabling us to effectively treat many areas of unmet medical need where current forms of medicine are largely ineffective. This will allow us to help many patients, as well as make heal
Product Development
Companies specializing in a variety of types of cells in vitro isolation, culture, amplification, induction, differentiation, and identification of basic research. Supporting the development of a variety of cell culture required separation liquid, medium
Production Platform
Domestic advanced cell technology research and development platform, cell and molecular clinical laboratories and in accordance with GMP standards established cell pilot production workshop and the international advanced professional equipment.
Jing-Meng's Milestone
Jing-Meng stem cells are advocates and promoters of domestic cell technical standards. Jing=Meng stem cells have received support and recognition from government and industry authorities in China and actively exploring the basic scientific research of cyt
Cooperation & Affiliation
• China Academy of Science (http://english.biols.cas.cn/news/news/201404/t20140414_119312.html) • Peking University International Hospital (http://en.pkucare.com/content/details23_59.html) • Peking University • Beijing Cancer Hospital • Developmen
Biologics Safety testing
Jing-Meng is a leading provider of cGMP and GLP biosafety testing services for biopharmaceutical drugs and vaccines with a strong customer focus around the world. Health authorities, including China Food and Drug Administration (CFDA), the US Food and Dr
Precision Medicine for Cancer Therapy Support
Even though researchers are making progress every day, the precision medicine approach to cancer treatment is not yet part of routine care for most patients. We have many new treatments designed to target a specific change are being tested right now in pr
Molecular Diagnosis
Jing-Meng early screening test can detect the disease at present 9 major categories of nearly 70 kinds of diseases, like common cardiovascular category, type of tumor, immune-metabolic disease and other major Chinese population can be detected
Medicinal Guided Gene Test – The Aim
Jing-Meng drug guidance gene testing currently available to five major categories of nearly 50 kinds of drug guidance, such as chemotherapy drugs, targeted drugs, high blood pressure drugs, transplant anti-rejection drugs, radiosensitivity and other commo
Company News
Duis aute irure dolor in reprehenderit in voluptate velit cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupid non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.